Nuon Therapeutics Raises $27M

San Mateo-based Nuon Therapeutics said this morning that it has completed a $27M, Series B financing. The funding was led by Frazier Healthcare Ventures and Domain Associates, and also included prior investors GBS Venture Partners of Australia. Nuon Therapeutics is focused on biotechnology for treating autoimmune and chronic inflammatory diseases and pain. Nuon was represented by Wilson, Sonsini, Goodrich & Rosati in the deal. The funding brings the company's total raised to $32M. More information »